Modern Authentication of Pharmaceuticals Act of 2025
Official title: To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.
What Do You Think?
How would you vote?
Vote to see the result.
What Happened in Congress?
Not yet voted on the floor.
Where the Bill Stands
- Introduced, done
- Committee, current stage
- Floor Vote, not yet
- Outcome, not yet
What This Bill Does
This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.
The bill applies to products manufactured beginning five years after the bill's enactment.
Sponsors
Related Documents
Timeline
- Library of CongressSponsor introductory remarks on measure. (CR H519)
- House floor actionsReferred to the House Committee on Energy and Commerce.
- Introduced
- Committee

Comments
Comments with insults, hate speech or personal information are removed.